MDxHealth Sees Progress in Talks to Partner Diagonistic Tests

MDxHealth (MDXH) SA said it made progress in talks with drugmakers about potential partnerships for its companion diagnostics tests.

The talks may or may not lead to an agreement and MdxHealth reiterated its forecast that it will sign a deal this year.

To contact the editor responsible for this story: John Martens at jmartens1@bloomberg.net

Press spacebar to pause and continue. Press esc to stop.

Bloomberg reserves the right to remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.